Details for Patent: 5,972,920
✉ Email this page to a colleague
Summary for Patent: 5,972,920
| Title: | Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders |
| Abstract: | One or more formulations for treating psoriasis and other skin disorders characterized by redness, itching, flaking, scaling, and plaque-type growth. The formulation includes a carrier component, one or more active ingredient components, and a surfactant component. The carrier preferably includes an alcohol in substantially equal volume with isopropyl myristate. The active ingredient component preferably includes a superpotent or high-potency corticosteroid such as clobetasol propionate, an anti-flaking ingredient such as zinc pyrithione, or a combination of the two. It may also include an anti-fungal compound. The surfactant component preferably includes an alkyl sulfate such as sodium lauryl sulfate. The formulations made by applied topically either in spray form or as a direct-contact liquid. |
| Inventor(s): | Seidel; William E. (Scarborough, ME) |
| Assignee: | Dermalogix Partners, Inc. (Scarborough, ME) |
| Application Number: | 09/022,995 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Composition; |
Drugs Protected by US Patent 5,972,920
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
